IDEAYA Biosciences (IDYA) Competitors

Legend Biotech (NASDAQ:LEGN) and IDEAYA Biosciences (NASDAQ:IDYA) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations.

Which has more volatility & risk, LEGN or IDYA?

Legend Biotech has a beta of 0.21, meaning that its share price is 79% less volatile than the S&P 500. Comparatively, IDEAYA Biosciences has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500.

Do analysts recommend LEGN or IDYA?

Legend Biotech presently has a consensus price target of $78.82, suggesting a potential upside of 130.19%. IDEAYA Biosciences has a consensus price target of $53.58, suggesting a potential upside of 180.98%. Given IDEAYA Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe IDEAYA Biosciences is more favorable than Legend Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Legend Biotech	0 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.92
IDEAYA Biosciences	0 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.93

Do insiders & institutionals believe in LEGN or IDYA?

70.9% of Legend Biotech shares are held by institutional investors. Comparatively, 98.3% of IDEAYA Biosciences shares are held by institutional investors. 0.0% of Legend Biotech shares are held by insiders. Comparatively, 3.5% of IDEAYA Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Does the media favor LEGN or IDYA?

In the previous week, Legend Biotech had 18 more articles in the media than IDEAYA Biosciences. MarketBeat recorded 24 mentions for Legend Biotech and 6 mentions for IDEAYA Biosciences. IDEAYA Biosciences' average media sentiment score of 1.12 beat Legend Biotech's score of 0.72 indicating that IDEAYA Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Legend Biotech	10 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IDEAYA Biosciences	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings & valuation, LEGN or IDYA?

IDEAYA Biosciences has lower revenue, but higher earnings than Legend Biotech. Legend Biotech is trading at a lower price-to-earnings ratio than IDEAYA Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Legend Biotech	$627.24M	10.03	-$518.25M	-$0.48	-71.33
IDEAYA Biosciences	$7M	238.48	-$274.48M	-$3.30	-5.78

Is LEGN or IDYA more profitable?

IDEAYA Biosciences has a net margin of 0.00% compared to Legend Biotech's net margin of -66.92%. IDEAYA Biosciences' return on equity of -26.74% beat Legend Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Legend Biotech	-66.92%	-29.69%	-19.45%
IDEAYA Biosciences	N/A	-26.74%	-25.54%

Does the MarketBeat Community prefer LEGN or IDYA?

IDEAYA Biosciences received 52 more outperform votes than Legend Biotech when rated by MarketBeat users. However, 72.58% of users gave Legend Biotech an outperform vote while only 71.72% of users gave IDEAYA Biosciences an outperform vote.

Company	Underperform	Outperform
Legend Biotech	Outperform Votes 90 72.58%	Underperform Votes 34 27.42%
IDEAYA Biosciences	Outperform Votes 142 71.72%	Underperform Votes 56 28.28%

Summary

IDEAYA Biosciences beats Legend Biotech on 14 of the 19 factors compared between the two stocks.